Skip to main content

Jill O’Donnell-Tormey, Ph.D.

Equibles does not estimate personal net worth.

Get an email with a short summary when Coherus Oncology, Inc. publishes a filing, an earnings call transcript or a press release.

Get CHRS alerts

About Jill O’Donnell-Tormey, Ph.D.

Jill O’Donnell-Tormey, Ph.D. is recorded as Board Member at Coherus Oncology, Inc. (CHRS) since May 18, 2022. Coherus Oncology, Inc. reported in an 8-K filed May 13, 2022 that Jill O’Donnell-Tormey, Ph.D. was appointed Class II director, effective May 18, 2022. Coherus Oncology, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Coherus Oncology, Inc. includes Dennis Lanfear (CEO), Bryan McMichael (CFO and Chief Accounting Officer), McDavid Stilwell (CFO) and 7 others.

“resolved that the vacancy on the Board created by such increase would be filled with the appointment of Jill O’Donnell-Tormey, Ph.D. effective May 18, 2022.”
Coherus Oncology, Inc. Form 8-K, filed May 13, 2022 · Read the filing

Affiliation history

Company network

Leadership on record at Coherus Oncology, Inc.

Recent activity